Published in Arch Phys Med Rehabil on January 01, 1979
Combined computer generated discharge documents and surgical audit. Br Med J (Clin Res Ed) (1986) 3.68
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol (2001) 8.88
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology (1996) 3.29
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology (1991) 2.53
Reliability of the Washington University Clinical Dementia Rating. Arch Neurol (1988) 2.48
Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest (1987) 2.41
Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest (1979) 2.02
Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med (1997) 1.91
Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Cancer Res (2001) 1.63
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med (1978) 1.59
Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology (2001) 1.50
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Ann Neurol (1988) 1.48
Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention. Ann Neurol (1992) 1.39
Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol (1987) 1.38
In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci U S A (1987) 1.31
Nodular pleuropulmonary rheumatoid disease. Report of two cases and review of literature. Am J Med (1967) 1.29
Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest (1985) 1.28
Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry (1989) 1.27
Cadmium accelerates bone loss in ovariectomized mice and fetal rat limb bones in culture. Proc Natl Acad Sci U S A (1988) 1.22
Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man. J Clin Invest (1982) 1.21
Inhibition by steroids of parathyroid hormone-induced Ca45 release from embryonic rat bone in vitro. J Pharmacol Exp Ther (1969) 1.19
Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D. N Engl J Med (1978) 1.16
Identification of a nucleolin binding site in human topoisomerase I. J Biol Chem (1996) 1.15
G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology (2005) 1.12
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry (2000) 1.11
Capricious behavior of pulmonary bullae developing fluid. Dis Chest (1968) 1.09
Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol (1984) 1.08
Abnormal regulation of circulating 25-hydroxyvitamin D in the Williams syndrome. N Engl J Med (1982) 1.08
Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. Nucleic Acids Res (1999) 1.07
Effects of glucagon on serum calcium in the rat and on bone resorption in tissue culture. Endocrinology (1970) 1.04
The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun (1983) 1.02
Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int (1984) 1.01
Comparison of fetal rat limb bones and neonatal mouse calvaria: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3. Calcif Tissue Int (1983) 1.01
Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest (1980) 0.96
Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism. N Engl J Med (1979) 0.96
Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning. Cancer Res (1997) 0.95
Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen. Nucleic Acids Res (1998) 0.94
A bioassay capable of measuring 1 picogram of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1978) 0.93
Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro (1984) 0.92
Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst (1986) 0.91
Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography. Anal Biochem (1980) 0.90
Parathyroid hormone and calcitonin modify inositol phospholipid metabolism in fetal rat limb bones. J Bone Miner Res (1986) 0.90
Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis. Biochem Pharmacol (1997) 0.90
Influence of divalent cations on regulation of cyclic GMP and cyclic AMP levels in brain tissue. J Neurochem (1976) 0.89
The progression of personality changes in senile dementia of the Alzheimer's type. J Am Geriatr Soc (1987) 0.89
Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I. J Biol Chem (2000) 0.89
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma. Ann Oncol (2012) 0.89
Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J Bone Miner Res (2000) 0.88
Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res (1996) 0.88
Comparison of the effects of depolarizing agents and neurotransmitters on regional CNS cyclic GMP levels in various animals. J Neurochem (1976) 0.88
Factors influencing stroke rehabilitation. Stroke (1971) 0.88
Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells. Proc Natl Acad Sci U S A (1982) 0.88
Quality in residency training: toward a broader, multidimensional definition. Acad Med (1996) 0.87
Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab (1997) 0.87
Enzymatic isolation of cells from neonatal calvaria using two purified enzymes from Clostridium histolyticum. Exp Cell Res (1983) 0.87
1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism. Acta Endocrinol (Copenh) (1983) 0.86
Isolation of osteoclasts from fetal rat long bones. Calcif Tissue Int (1982) 0.85
Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells. Biochem Pharmacol (1998) 0.85
In vitro activation of irinotecan to SN-38 by human liver and intestine. Anticancer Res (1999) 0.85
Calcium transport in isolated bone cells. III. Effects of parathyroid hormone and cyclic 3',5'-AMP. Endocrinology (1975) 0.85
Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology (1992) 0.84
Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res (2000) 0.84
Potassium effects on bone: comparison of two model systems. Am J Physiol (1983) 0.84
Bone resorbing activity of vitamin D metabolites and congeners in vitro: influence of hydroxyl substituents in the A ring. Endocrinology (1975) 0.84
Bone anabolic responses to mechanical load in vitro involve COX-2 and constitutive NOS. Connect Tissue Res (2004) 0.84
Mechanisms of resistance to camptothecins. Ann N Y Acad Sci (2000) 0.84
Cytotoxic activity, tumor accumulation, and tissue distribution of ruthenium-103-labeled bleomycin. J Natl Cancer Inst (1981) 0.84
The D vitamins and bone. Pharmacol Rev (1980) 0.84
Intralobar pulmonary sequestration: aortographic demonstration. Dis Chest (1966) 0.84
U-73122, a phospholipase C antagonist, inhibits effects of endothelin-1 and parathyroid hormone on signal transduction in UMR-106 osteoblastic cells. Biochim Biophys Acta (1994) 0.84
Post-acute dispositions of older adults hospitalized for depression. Aging Ment Health (2006) 0.83
Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro. J Pharmacol Exp Ther (1984) 0.83
Diurnal rhythms in Ca transfer into bone, Ca release from bone, and bone resorbing activity in serum of rats. Am J Physiol (1992) 0.82
A monolog on analogs: in vitro effects of vitamin D metabolites and consideration of the mineralization question. Calcif Tissue Int (1981) 0.82
Effects of facilitation exercise techniques in stroke rehabilitation. Arch Phys Med Rehabil (1970) 0.82
Identification of topoisomerase I mutations affecting both DNA cleavage and interaction with camptothecin. Ann N Y Acad Sci (1996) 0.82
The quality of psychiatric residency : the assessment of programs and options for distributing psychiatric residents in the service of health care reform. Acad Psychiatry (1999) 0.82
Studies on the mechanism of desensitization of the parathyroid hormone-stimulated calcium signal in UMR-106 cells: reversal of desensitization by alkaline phosphatase but not by protein kinase C downregulation. J Bone Miner Res (1994) 0.82
MicroCT quantification of in vitro bone resorption of neonatal murine calvaria exposed to IL-1 or PTH. J Struct Biol (2004) 0.81
Symptoms of "depression" in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord (1988) 0.81
10-Keto or 25-hydroxy substitution confer equivalent in vitro bone-resorbing activity to vitamin D3. Arch Biochem Biophys (1985) 0.81
Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest (1981) 0.81
Measurement of cyclic nucleotides in histologically defined samples of brain and retina. Anal Biochem (1977) 0.81
Clinical diagnosis and course of Alzheimer's disease. Psychiatr Clin North Am (1991) 0.81
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim Biophys Acta (2000) 0.81
Levodopa therapy effects on natural history of Parkinsonism. Arch Neurol (1972) 0.81
The safety of ECT in geriatric psychiatry. J Am Geriatr Soc (1987) 0.81
Psychiatric correlates of chronic solvent abuse. J Clin Psychiatry (1987) 0.80
Vertebral bone resorption in vitro: effects of parathyroid hormone, calcitonin, 1,25 dihydroxyvitamin D3, epidermal growth factor, prostaglandin E2, and estrogen. Calcif Tissue Int (1987) 0.80
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial. Diabetes Care (1995) 0.80
The preparation of [35S]homocysteine thiolactone free of [35S]methionine. J Biochem Biophys Methods (1982) 0.79
Reduced free-methionine in methionine-dependent SV40-transformed human fibroblasts synthesizing apparently normal amounts of methionine. J Cell Physiol (1983) 0.79
Sex differences in the sensitivity of two self-report depression scales in older depressed inpatients. Psychol Aging (1994) 0.79
Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Bone (2004) 0.79
Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction. Anticancer Drugs (1999) 0.79
Interaction between amrinone and parathyroid hormone on bone in culture. Am J Physiol (1982) 0.79
Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bones in vitro. Mol Pharmacol (1976) 0.79
Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment. Ann Neurol (1990) 0.79
Bone resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Biochem Biophys Res Commun (1975) 0.79